Simon Waddington
Founder chez Cambium, Inc. /US/
Profil
Simon Waddington is the founder of Cambium, Inc. He currently works as a Director at Biotechnology Innovation Organization.
Previously, he worked as President & CEO at Abunda Nutrition, Inc., CEO at Evolva, Inc., and Chairman at Zimitech, Inc. He also served as a Non-Executive Director at Plastic Logic, Inc. and as an Entrepreneur-in-Residence at Burrill LLC.
He was the Managing Partner at PolyTechnos Venture-Partners GmbH from 1998 to 2007.
He also worked as Manager-Product Development at Zeneca Garden Care.
Dr. Waddington holds a doctorate from The University of Liverpool and an MBA from Harvard Business School.
Postes actifs de Simon Waddington
| Sociétés | Poste | Début |
|---|---|---|
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Director/Board Member | - |
Cambium, Inc. /US/
 Cambium, Inc. /US/ Miscellaneous Commercial ServicesCommercial Services Cambium, Inc. provides research services. The company is based in Berkeley, CA. The company was founded by Stephan Herrera, Simon Waddington, Andrew Guenthner. Simon Waddington has been the CEO since incorporation. | Founder | - |
Anciens postes connus de Simon Waddington
| Sociétés | Poste | Fin |
|---|---|---|
| EVOLVA HOLDING SA | Chief Executive Officer | 10/07/2018 |
PolyTechnos Venture-Partners GmbH
 PolyTechnos Venture-Partners GmbH Investment ManagersFinance PolyTechnos Venture-Partners II GmbH (PTVP) is an independent partner-owned European private equity firm established in 1998 and based in Munich with a U.S. office in Silicon Valley. Their clients include financial institutions, banks, insurance companies, universities, foundations, corporations and fund-of-funds. They operate in close relationship with U.S. venture capital firms based on the West Coast. PTVP manages and divests a portfolio of private equity participations held through two maturing funds, namely the German fund PolyTechnos Venture Fund II and the UK fund Enabling Technology. PTVP's successor firm PT Capital-Partners GmbH was established in 2008. | Private Equity Investor | 05/11/2007 |
Zimitech, Inc.
 Zimitech, Inc. BiotechnologyHealth Technology Zimitech, Inc. engages in the development of yeast-based technologies for production of sugar. It focuses on missing components found in breast milk. The company is headquartered in Oakland, CA. | Chairman | - |
Abunda Nutrition, Inc.
 Abunda Nutrition, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Evolva Holding SA, Abunda Nutrition, Inc. discovers, develops and commercializes next-generation food ingredients and product solutions. The private company is based in San Francisco, CA. Abunda Nutrition was acquired by Evolva Holding SA on July 08, 2011 for $56.98 million. | Chief Executive Officer | - |
| Evolva, Inc. | Chief Executive Officer | - |
Formation de Simon Waddington
| The University of Liverpool | Doctorate Degree |
| Harvard Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| EVOLVA HOLDING SA | Consumer Non-Durables |
| Entreprise privées | 10 |
|---|---|
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Cappella, Inc.
 Cappella, Inc. Pharmaceuticals: MajorHealth Technology Cappella, Inc. operates as a medical device company, which develops novel solutions for the treatment of complex coronary artery disease (CAD) and specifically bifurcation vascular disease. The company was founded by Antonio Columbo and Ascher Shmulewitz in 2004 and is headquartered in Boston, MA. | Health Technology |
Burrill LLC
 Burrill LLC Investment ManagersFinance Burril LLC (Burrill) is a private equity/venture capital firm founded in 1994 by G. Steven. The firm is headquartered in San Francisco, California. | Finance |
Zeneca Garden Care
 Zeneca Garden Care Pharmaceuticals: OtherHealth Technology Part of AstraZeneca PLC, Zeneca Garden Care is a British company that develops and manufactures pharmaceutical products, agrochemicals, and specialty chemicals. The private company is based in Macclesfield, UK. Zeneca Garden Care was acquired by Zeneca Group Plc on January 01, 1995 for $84.16 million. | Health Technology |
Plastic Logic, Inc.
 Plastic Logic, Inc. Packaged SoftwareTechnology Services Plastic Logic, Inc. develops plastic electronic technology solutions. is a private company that develops plastic electronic technology solutions. The comoany was founded by Stuart M. Evans, Richard Friend, Henning Sirringhaus in 2000 and it is headquartered in Mountain View, CA. | Technology Services |
PolyTechnos Venture-Partners GmbH
PolyTechnos Venture-Partners GmbH Investment ManagersFinance PolyTechnos Venture-Partners II GmbH (PTVP) is an independent partner-owned European private equity firm established in 1998 and based in Munich with a U.S. office in Silicon Valley. Their clients include financial institutions, banks, insurance companies, universities, foundations, corporations and fund-of-funds. They operate in close relationship with U.S. venture capital firms based on the West Coast. PTVP manages and divests a portfolio of private equity participations held through two maturing funds, namely the German fund PolyTechnos Venture Fund II and the UK fund Enabling Technology. PTVP's successor firm PT Capital-Partners GmbH was established in 2008. | Finance |
Abunda Nutrition, Inc.
Abunda Nutrition, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Evolva Holding SA, Abunda Nutrition, Inc. discovers, develops and commercializes next-generation food ingredients and product solutions. The private company is based in San Francisco, CA. Abunda Nutrition was acquired by Evolva Holding SA on July 08, 2011 for $56.98 million. | Commercial Services |
| Evolva, Inc. | |
Zimitech, Inc.
Zimitech, Inc. BiotechnologyHealth Technology Zimitech, Inc. engages in the development of yeast-based technologies for production of sugar. It focuses on missing components found in breast milk. The company is headquartered in Oakland, CA. | Health Technology |
Cambium, Inc. /US/
Cambium, Inc. /US/ Miscellaneous Commercial ServicesCommercial Services Cambium, Inc. provides research services. The company is based in Berkeley, CA. The company was founded by Stephan Herrera, Simon Waddington, Andrew Guenthner. Simon Waddington has been the CEO since incorporation. | Commercial Services |
